Cognitive manifestations of Huntington disease in relation to genetic structure and clinical onset

Archives of Neurology

Volumn 54, Issue 9, 1997, Pages 1081-1088

  Jason, Gregor W ^a,b   Suchowersky, Ohsana ^a   Pajurhova, Eva M ^a   Graham, Lisa ^a   Klimek, Mary Lou ^a   Garber, Anthony T ^a   Poirier Heine, Danielle ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; GENE STRUCTURE; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; INTELLIGENCE; LANGUAGE ABILITY; MALE; MEMORY; MOTOR PERFORMANCE; ONSET AGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK ASSESSMENT; SPATIAL ORIENTATION;

EID: 0030882268     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550210019008     Document Type: Article

References (69)

1. Bamford KA, Caine ED, Kido DK, Plassche WM, Shoulson I. Clinical-pathologic correlation in Huntington's disease: a neuropsychological and computed tomography study. Neurology. 1989;39:796-801.
2. Butters N, Sax D, Montgomery K, Tarlow S. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch Neural. 1978:35:585-589.
3. Caine ED, Hunt RD, Weingartner H, Ebert MH. Huntington's dementia: clinical and neuropsychological features. Arch Gen Psychiatry. 1978:35:377-384.
4. Fisher JM, Kennedy JL, Caine ED, Shoulson I. Dementia in Huntington disease: a cross-sectional analysis of intellectual decline. In: Mayeux R, Rosen WG, eds. The Dementias. New York, NY: Raven Press; 1983:229-238.
5. Lundervold AJ, Reinvang I. Neuropsychological findings and depressive symptoms in patients with Huntington's disease. Scand JPsychol. 1991 ;32:275-283.
6. Moses JA, Golden CJ, Berger PA, Wisniewski AM. Neuropsychological deficits in early, middle, and late stage Huntington's disease as measured by the LuriaNebraska Neuropsychological Battery. Int J Neurosci, 1981;! 4:95-100.
7. Webb M, Trzepacz PT. Huntington's disease: correlations of mental status with chorea. Biol Psychiatry. 1987;22:751-761.
8. Huber SJ, Paulson GW. Memory impairment associated with progression of Huntington's disease. Cortex. 1987;23:275-283.
9. Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME, Folstein SE. Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases. J Clin Exp Neuropsychol. 1987;9:650-664.
10. Fragassi NA, Stanzione M, Angelini R, Di Maio L. Malattia di Huntington: correlazioni cliniche e neuropsicologiche, dati preliminari. Acta Neurol. 1992;14: 530-536.
11. Goodman RM, Hall CL Jr, Terango L, et al. Huntington's chorea: a multidisciplinary study of affected parents and first generation offspring. Arch Neurol. 1966; 15:345-355.
12. Fedio P, Cox CS, Neophytides A, et al. Neuropsychological profile of Huntington's disease: patients and those at risk. Adv Neurol. 1979;23:239-255.
13. Josiassen RC, Curry LM, Mancall EL. Development of neuropsychological deficits in Huntington's disease. Arch Neurol. 1983:40:791-796.
14. Lyle OE, Gottesman II. Premorbid psychometric indicators of the gene for Huntington's disease. J Consult Clin Psychol. 1977;45:1011 -1022.
15. Lanto AB, Riege WH, Mazziotta JC, Pahl JJ, Phelps ME. Increased false alarms in a subset of persons at-risk for Huntington's disease. Arch Clin Neuropsychol. 1990;5:393-404.
16. Baro F. A neuropsychological approach to early detection of Huntington's chorea. Adv Neurol. 1973;1:329-338.
17. Oepen G, Mohr U, Willmes K, et al. Huntington's disease: visuomotor disturbance in patients and offspring. J Neurol Neurosurg Psychiatry. 1985;48:426433.
18. Wexler NS. Perceptual-motor, cognitive, and emotional characteristics of persons at risk for Huntington's disease. Adv Neurol. 1979:23:257-271.
19. Hayward L, Zubrick SR, Hall W. Early sensory-perceptual changes in Huntington's disease. Aust N Z J Psychiatry. 1985;19:384-389.
20. Josiassen RC, Curry L, Roemer RA, DeBease C, Mancall EL. Patterns of intellectual deficit in Huntington's disease. JClin Neuropsychol. 1982;4:173-183.
21. Catona MC, Lazzarini AM, McCormack MK. A psychometric study of children atrisk for Huntington disease. Clin Genet. 1985;28:307-316.
22. Johnson CT, McSorley P, Brandt J, et al. Memory test performance as a preclinical indicator of Huntington's disease in at-risk persons? J Clin Exp Neun- \ psychol. 1987;9:51.
23. Strauss ME, Brandt J. Is there increased WAIS pattern variability in Huntington's disease? J Clin Exp Neuropsychol. 1985;7:122-126.
24. Strauss ME, Brandt J. Attempt at preclinical identification of Huntington's disease using the WAIS. JClin Exp Neuropsychol. 1986:8:210-218.
25. Cala LA, Black JL, Collins DWK, Ellison RM, Zubrick SA. Thirteen years longitudinal study of computed tomography, visual electrophysiology and neuropsychological changes in Huntington's chorea patients and 50% at-risk asymptomatic subjects. Clin Exp Neural. 1990;27:43-63.
26. Lyle OE, Quast W. The Bender gestalt: use of clinical judgment vs recall scores in prediction of Huntington's disease. J Consult Clin Psychol. 1976:44:229-232.
27. Jason GW, Pajurkova EM, Suchowersky 0, et al. Presymptomatic neuropsychological impairment in Huntington's disease. Arch Neural. 1988:45:769-773.
28. Diamond R, White RF, Myers RH, et al. Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol. 1992:14:961-975.
29. Lundervold AJ, Reinvang I. Variability in cognitive function among persons at high genetic risk of Huntington's disease. Acta NeurolScand. 1995;91:462-469.
30. Blackmore L, Simpson SA, Crawford JR. Cognitive performance in UK sample of presymptomat'c people carrying the gene for Huntington's disease. JMed Genet 1995:32:358-362.
31. Strauss ME, Brandt J. Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals? Arch Neurol. 1990; 47:905-908.
32. Bylsma FW, Brandt J, Strauss ME. Personal and extrapersonal orientation in Huntington's disease patients and those at risk. Cortex. 1992:28:113-122.
33. Giordani B, Berent S, Boivin MJ, et al. Longitudinal neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch Neurol. 1995:52:59-64.
34. Rothlind JC, Brandt J, Zee D, Codori AM, Folstein S. Unimpaired verbal memory and oculomotor control in asymptomatic adults with the genetic marker for Huntington's disease. Arch Neurol. 1993:50:799-802.
35. Faught E, Falgout JC, Leli DA. Late-onset variant of Huntington's chorea. South MedJ. 1983:76:1266-1270.
36. Britton JW, Uitti RJ, Ahlskog JE, et al. Hereditary late-onset chorea without significant dementia: genetic evidence for substantial phenotypic variation in Huntington's disease. Neurology. 1995:45:443-447.
37. Myers RH, Sax DS, Schoelfeld M, Bird ED, et al. Late onset of Huntington's disease. J Neurol Neurosurg Psychiatry. 1985:48:530-534.
38. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 1993:72:971-983.
39. Duyao M, Ambrose CM, Myers RM, et al. Trinucleotide repeat length instability and age of onset in Huntington's disease. Nat Genet. 1993:4:387-392.
40. Furtado S, Suchowersky 0, Rewcastle NB, Graham L, Klimek ML, Garber A. Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann Neurol. 1996:39:132-136.
41. Illarioshkin SN, Igarashi S, Onodera 0, et al. Trinucleotide repeat length and rate of progression of Huntington's disease. Ann Neurol. 1994:36:630-635.
42. Brandt J, Bylsma FW, Gross BA, Stine OC, Ranen N, Ross ÇA. Trinucleotide repeat length and clinical progression in Huntington's disease. Neurology. 1996; 46:527-531.
43. Andrew SE, Goldberg YP, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet. 1993;4:398-403.
44. Fouroud T, Siemers E, Kleindorfer D, et el. Cognitive scores in carriers of Huntington's disease gene compared to noncarriers. Ann Neurol. 1995:37:657-664.
45. Siemers E, Fouroud T, Bill DJ, et al. Motor changes in presymptomatic Huntington disease gene carriers. Arch Neural. 1996;53:487-492.
46. Wechsler D. Wechsler Adult Intelligence Scale. New York, NY: Psychological Corp; 1955.
47. Wechsler D. Wechsler Memory Scale. New York, NY: Psychological Corp; 1945.
48. Rey A. L'examen psychologique dans les cas d'encéphalopathie traumatique. Arch Psychol. 1942;28:286-340.
49. Taylor LB. Localisation of cerebral lesions by psychological testing. Clin Neurosurg. 1969:16:269-287.
50. Pajurkova EM, Wilkins AJ. Prospective remembering in patients with unilateral temporal or frontal lobectomies. Int NeuropsycholSoc Bull. June 1983:20.
51. Reitan RM, Davison LA. Clinical Neuropsychology: Current Status and Applications. Washington, DC: VH Winston & Sons; 1974.
52. Berg EA. A simple objective technique for measuring flexibility in thinking. JGen Psychol. 1948;39:15-22.
53. Thurstone LL, Thurstone TG. The Chicago Tests of Primary Mental Abilities. Chicago, III: Science Research Associates; 1943.
54. Jones-Gotman M, Milner B. Design fluency: the invention of nonsense drawings after focal cortical lesions. Neuropsychologia. 1977;15:653-674.
55. Golden CJ. The Stroop Color and Word Test: A Manual for Clinical and Experimental Uses. Chicago, III: Stoelting Co; 1978.
56. Wa'rrington EK, Rabin P. Perceptual matching in patients with cerebral lesions. Neuropsychologia. 1970;8:475-487.
57. Culver CM. Test of left-right discrimination. Percept Mot Skills. 1969;29:863867.
58. Oldfield RC, Wingfield A. The time it takes to name an object. Nature. 1964;202: 1031-1032.
59. Chapman JC. Chapman-Cook Speed of Reading Test. Minneapolis, Minn: Educational Publishers; 1924.
60. Durrell DD. Durrell Analysis of Reading Difficulty. New York, NY: Harcourt Brace & World; 1955.
61. De Renzi E, Vignolo LA. The Token Test: a sensitive test to detect receptive disturbances in aphasies. Brain. 1962;85:665-678.
62. Bender MB. Extinction and precipitation of cutaneous sensations. Arch Neurol Psychiatry. 1945;54:1-9.
63. Corkin S, Milner B, Rasmussen T. Somatosensory thresholds. Arch Neurol. 1970; 23:41-58.
64. McNairDM, LorrM, Droppleman LF. EITS Manual for the Profile of Mood States. San Diego, Calif: Educational and Industrial Testing Service; 1971.
65. Bornstein RA, Baker GB, Bazylewich T, Douglass AB. Tourette syndrome and neuropsychological performance. Acta Psychiatr Scand. 1991:84:212-216.
66. Kiernan RJ, Matthews CG. Impairment index versus T-score averaging in neuropsychological assessment. JConsw//C//V7Psyc/)oJ. 1976:44:951-957.
67. Hayden MR, Hewitt J, Stoessl AJ, et al. The combined use of positron emission tomography and DNA polymorphisms for preclinical detection of Huntington disease. Neurology. 1987;37:1441-1447.
68. Aylward EH, Brandt J, Codori AM, et al. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology. 1994;44:823-828.
69. Mendez MF, Adams NL, Lewandowski KS. Neurobehavioral changes associated with caudate lesions. Neurology. 1989:39:349-354.